THC Stock - Tenet Healthcare Corporation
Unlock GoAI Insights for THC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $20.66B | $20.55B | $19.17B | $19.48B | $17.64B |
| Gross Profit | $8.21B | $7.80B | $7.05B | $7.27B | $6.23B |
| Gross Margin | 39.7% | 38.0% | 36.8% | 37.3% | 35.3% |
| Operating Income | $5.96B | $2.51B | $2.33B | $2.87B | $1.99B |
| Net Income | $3.20B | $611.00M | $411.00M | $914.00M | $399.00M |
| Net Margin | 15.5% | 3.0% | 2.1% | 4.7% | 2.3% |
| EPS | $33.02 | $6.01 | $3.84 | $8.55 | $3.80 |
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 14th 2025 | Goldman | Resumed | Buy | $224 |
| July 28th 2025 | Wolfe Research | Downgrade | Peer Perform | - |
| May 29th 2025 | Wells Fargo | Upgrade | Overweight | $195 |
| April 15th 2025 | Robert W. Baird | Downgrade | Neutral | $137 |
| March 26th 2025 | Morgan Stanley | Initiation | Overweight | $165 |
| February 26th 2025 | TD Cowen | Initiation | Buy | $175 |
| December 17th 2024 | JP Morgan | Resumed | Overweight | $175 |
| December 16th 2024 | Goldman | Downgrade | Neutral | $140← $196 |
| November 25th 2024 | Wells Fargo | Downgrade | Equal Weight | $150← $205 |
| November 22nd 2024 | Raymond James | Downgrade | Outperform | $195 |
| October 11th 2024 | KeyBanc Capital Markets | Initiation | Overweight | $200 |
| May 30th 2024 | Robert W. Baird | Initiation | Outperform | $153 |
| March 27th 2024 | Wolfe Research | Upgrade | Outperform | $122 |
| March 6th 2024 | Barclays | Initiation | Overweight | $113 |
| April 21st 2023 | Cantor Fitzgerald | Initiation | Overweight | $73 |
Earnings History & Surprises
THCEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Feb 11, 2026 | $4.05 | — | — | — |
Q4 2025 | Oct 28, 2025 | $3.33 | $3.70 | +11.1% | ✓ BEAT |
Q3 2025 | Jul 22, 2025 | $2.87 | $4.02 | +40.1% | ✓ BEAT |
Q2 2025 | Apr 29, 2025 | $3.12 | $4.36 | +39.7% | ✓ BEAT |
Q1 2025 | Feb 12, 2025 | $2.95 | $3.44 | +16.6% | ✓ BEAT |
Q4 2024 | Oct 29, 2024 | $2.33 | $2.93 | +25.8% | ✓ BEAT |
Q3 2024 | Jul 24, 2024 | $1.90 | $2.31 | +21.6% | ✓ BEAT |
Q2 2024 | Apr 30, 2024 | $1.45 | $3.22 | +122.1% | ✓ BEAT |
Q1 2024 | Feb 8, 2024 | $1.60 | $2.68 | +67.5% | ✓ BEAT |
Q4 2023 | Oct 30, 2023 | $1.20 | $1.44 | +20.0% | ✓ BEAT |
Q3 2023 | Jul 31, 2023 | $1.25 | $1.44 | +15.2% | ✓ BEAT |
Q2 2023 | Apr 25, 2023 | $1.16 | $1.42 | +22.4% | ✓ BEAT |
Q1 2023 | Feb 9, 2023 | $1.23 | $1.96 | +59.3% | ✓ BEAT |
Q4 2022 | Oct 20, 2022 | $1.28 | $1.44 | +12.5% | ✓ BEAT |
Q3 2022 | Jul 21, 2022 | $0.79 | $1.50 | +89.9% | ✓ BEAT |
Q2 2022 | Apr 20, 2022 | $1.04 | $1.93 | +85.6% | ✓ BEAT |
Q1 2022 | Feb 7, 2022 | $1.49 | $2.70 | +81.2% | ✓ BEAT |
Q4 2021 | Oct 20, 2021 | $1.09 | $1.99 | +82.6% | ✓ BEAT |
Q3 2021 | Jul 21, 2021 | $1.09 | $1.59 | +45.9% | ✓ BEAT |
Latest News
Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $257
📈 PositiveBarclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $240
📈 PositiveJP Morgan Maintains Overweight on Tenet Healthcare, Raises Price Target to $230
📈 PositiveWells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $252
📈 PositiveShares of health insurers are trading higher amid a possible rebound after President Trump recently proposed that healthcare funding should go directly to people. On Monday, the Senate passed its shutdown-ending bill that lacked a provision to extend Obamacare subsidies; however, the Democrats secured a commitment to vote on credits in December.
📈 PositiveTruist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $240
📈 PositiveRBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $252
📈 PositiveUBS Maintains Buy on Tenet Healthcare, Raises Price Target to $260
📈 PositiveCantor Fitzgerald Maintains Overweight on Tenet Healthcare, Raises Price Target to $245
📈 PositiveGuggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $238
📈 PositiveTenet Healthcare Raises FY2025 GAAP EPS Guidance from $14.05-$15.15 to $14.66-$15.37 vs $14.78 Est
📈 PositiveTenet Healthcare Raises FY2025 Adj EPS Guidance from $15.55-$16.21 to $15.93-$16.26 vs $15.68 Est; Raises FY2025 Sales Guidance from $20.950B-$21.250B to $21.150B-$21.350B vs $21.133B Est
📈 PositiveTenet Healthcare Q3 Adj. EPS $3.70 Beats $3.30 Estimate, Sales $5.289B Beat $5.252B Estimate
📈 PositiveMizuho Maintains Outperform on Tenet Healthcare, Raises Price Target to $225
📈 PositiveGoldman Sachs Assumes Tenet Healthcare at Buy, Announces Price Target of $224
📈 PositiveKeybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $225
📈 PositiveWells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $238
📈 PositiveCantor Fitzgerald Reiterates Overweight on Tenet Healthcare, Maintains $190 Price Target
📈 PositiveBarclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $229
📈 PositiveB of A Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $225
📈 PositiveFrequently Asked Questions about THC
What is THC's current stock price?
What is the analyst price target for THC?
What sector is Tenet Healthcare Corporation in?
What is THC's market cap?
Does THC pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to THC for comparison